JP2025517100A5 - - Google Patents
Info
- Publication number
- JP2025517100A5 JP2025517100A5 JP2024563866A JP2024563866A JP2025517100A5 JP 2025517100 A5 JP2025517100 A5 JP 2025517100A5 JP 2024563866 A JP2024563866 A JP 2024563866A JP 2024563866 A JP2024563866 A JP 2024563866A JP 2025517100 A5 JP2025517100 A5 JP 2025517100A5
- Authority
- JP
- Japan
- Prior art keywords
- chain
- amino acid
- sequence
- serum albumin
- fusion protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210491720.7 | 2022-05-07 | ||
| CN202210491720 | 2022-05-07 | ||
| PCT/CN2023/092214 WO2023216981A1 (zh) | 2022-05-07 | 2023-05-05 | 松弛素或类似物的融合蛋白及其医药用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025517100A JP2025517100A (ja) | 2025-06-03 |
| JP2025517100A5 true JP2025517100A5 (enExample) | 2026-05-14 |
Family
ID=88729678
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024563866A Pending JP2025517100A (ja) | 2022-05-07 | 2023-05-05 | リラキシン又は類似体の融合タンパク質及びその医薬的使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250312444A1 (enExample) |
| EP (1) | EP4524156A4 (enExample) |
| JP (1) | JP2025517100A (enExample) |
| KR (1) | KR20250009454A (enExample) |
| CN (1) | CN119032105A (enExample) |
| AU (1) | AU2023266749A1 (enExample) |
| CA (1) | CA3252059A1 (enExample) |
| MX (1) | MX2024013712A (enExample) |
| TW (1) | TW202409074A (enExample) |
| WO (1) | WO2023216981A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023086913A2 (en) | 2021-11-11 | 2023-05-19 | Tectonic Therapeutic, Inc. | Relaxin-2 fusion protein analogs and methods of using same |
| EP4713001A2 (en) | 2023-05-18 | 2026-03-25 | Tectonic Operating Company, Inc. | Relaxin-2 fusion protein analogs and methods of using same |
| CN122122198A (zh) * | 2023-11-08 | 2026-05-29 | 北京拓界生物医药科技有限公司 | 融合蛋白及其医药用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1247080A (en) | 1983-03-08 | 1988-12-20 | Commonwealth Serum Laboratories Commission | Antigenically active amino acid sequences |
| DE69334275D1 (de) | 1992-08-21 | 2009-05-20 | Univ Bruxelles | Immunoglobuline ohne Leichtkette |
| CA2766160A1 (en) * | 2000-12-12 | 2002-08-08 | William Dall'acqua | Modified molecules with increased affinity for fcrn, compositions, and uses thereof |
| US7771951B2 (en) | 2001-12-03 | 2010-08-10 | Amgen Fremont Inc. | Antibody categorization based on binding characteristics |
| US8921528B2 (en) * | 2004-06-01 | 2014-12-30 | Domantis Limited | Bispecific fusion antibodies with enhanced serum half-life |
| US20100113339A1 (en) | 2006-09-08 | 2010-05-06 | Ablynx N. V. | Serum albumin binding proteins with long half-lives |
| AU2012283235A1 (en) * | 2011-07-08 | 2014-01-09 | Bayer Intellectual Property Gmbh | Fusion proteins releasing Relaxin and uses thereof |
| KR20160071472A (ko) | 2013-11-07 | 2016-06-21 | 샹하이 헨그루이 파마수티컬 컴퍼니 리미티드 | 인간 릴렉신 유사체, 이의 약제학적 조성물 및 이의 약제학적 적용 |
| WO2018138170A1 (en) * | 2017-01-25 | 2018-08-02 | Medimmune, Llc | Relaxin fusion polypeptides and uses thereof |
| TWI844709B (zh) | 2019-07-31 | 2024-06-11 | 美商美國禮來大藥廠 | 鬆弛素(relaxin)類似物及其使用方法 |
| CN112409480B (zh) * | 2019-08-20 | 2024-08-27 | 四川科伦博泰生物医药股份有限公司 | 结合血清白蛋白的蛋白及其用途 |
| CN112851805B (zh) * | 2019-11-12 | 2025-09-09 | 四川科伦博泰生物医药股份有限公司 | 一种结合血清白蛋白的蛋白及其用途 |
| CR20230015A (es) | 2020-06-17 | 2023-02-17 | Medimmune Ltd | Fusiones heterodiméricas de relaxina y usos de las mismas |
-
2023
- 2023-05-05 JP JP2024563866A patent/JP2025517100A/ja active Pending
- 2023-05-05 WO PCT/CN2023/092214 patent/WO2023216981A1/zh not_active Ceased
- 2023-05-05 CN CN202380032234.1A patent/CN119032105A/zh active Pending
- 2023-05-05 US US18/863,311 patent/US20250312444A1/en active Pending
- 2023-05-05 TW TW112116886A patent/TW202409074A/zh unknown
- 2023-05-05 EP EP23802753.6A patent/EP4524156A4/en active Pending
- 2023-05-05 CA CA3252059A patent/CA3252059A1/en active Pending
- 2023-05-05 AU AU2023266749A patent/AU2023266749A1/en active Pending
- 2023-05-05 KR KR1020247039736A patent/KR20250009454A/ko active Pending
-
2024
- 2024-11-06 MX MX2024013712A patent/MX2024013712A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7412521B2 (ja) | Ｃｄ４７に対するヒト化及びキメラモノクローナル抗体 | |
| JP7019198B2 (ja) | 補体関連疾患の予防及び治療のためのｃ５抗体及び方法 | |
| US6881557B2 (en) | Super humanized antibodies | |
| AU2016304764B2 (en) | Antigen binding constructs to target molecules | |
| AU2013329381B2 (en) | Antibodies recognizing alpha-synuclein | |
| US10562973B2 (en) | Blood-brain barrier shuttles containing antibodies recognizing alpha-synuclein | |
| JP2010515427A5 (enExample) | ||
| CN103479998A (zh) | 聚乙二醇化的Aβ FAB | |
| TW200827373A (en) | Humanized anti-factor D antibodies and uses thereof | |
| JP2023502968A5 (enExample) | ||
| HUT67796A (en) | Specific binding antibodies | |
| JP2021512159A5 (enExample) | ||
| KR20240107202A (ko) | 항-트랜스페린 수용체 항체 및 이의 용도 | |
| US20240092875A1 (en) | Sars-cov-2 antibodies for treatment and prevention of covid-19 | |
| TW201143789A (en) | Antigen binding proteins | |
| JP7788996B2 (ja) | 新規抗Ｎｏｇｏ－Ａ抗体 | |
| JP7725069B2 (ja) | 抗ｔｆｐｉモノクローナル抗体 | |
| RU2024135573A (ru) | Слитый белок релаксина или его аналога и его медицинское применение | |
| WO2022140659A2 (en) | Anti-cd47 antibodies and uses thereof |